Terry Jo Bichell worked as a documentary filmmaker in the early days of videotape, then became a public health nurse-midwife after filming a difficult birth in West Africa. When her youngest child, Lou, was diagnosed with Angelman syndrome, she switched from midwifery to clinical research on Angelman syndrome. Eventually, she went back to school to earn a PhD in neuroscience from Vanderbilt University in an effort to find treatments for her son. Along the way, she studied gene-environment interactions in Huntington disease as well as circadian aspects of Angelman syndrome and was a columnist for HDBuzz. After graduating, she was the Founding Director of the Angelman Biomarkers and Outcome Measures Alliance until 2018. Dr. Bichell founded a new non-profit in 2019, COMBINEDBrain (Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders), to assist other rare and ultra-rare neurogenetic disorders with clinical trial preparations.
You may also like
78 - Therapeutic Strategies for Autism: Targeting Three Levels of the Central Dogma of Molecular Biology - Presented to the SYNGAP1 Community
Prof. Lilia Iakoucheva, Ph.D. & Mr. Derek Hong, M.S.
UCSD School of Medicine
76 - Involvement of the brain endothelium in neurodevelopmental disorders like SYNGAP1
Baptiste Lacoste, PhD
The University of Ottawa
79 - Quantifying perturbed SynGAP1 function caused by coding mutations
Michael Courtney, PhD
Turku Bioscience Centre, Finland